Delitto and Team Receive SCI Grant
August 14, 2023
Dr. Dan Delitto
A project led by Dr. Dan Delitto et al was selected for funding as one of the Stanford Cancer Institute’s (SCI) 2023 October – Innovation Awards. The project, titled “Elucidating mechanisms of lymph node metastatic tolerance in high risk resectable cholangiocarcinoma,” will receive $46,300 over a 12-month period.
“This project is based on an upcoming trial evaluating neoadjuvant immunotherapy in the treatment of cholangiocarcinoma,” said Delitto. “The focus is on evaluating the regional lymph nodes, leveraging Dr. Ed Engleman’s expertise in this arena.”
Dr. Edgar G. Engleman is a professor of pathology and of medicine in the divisions of immunology and rheumatology. The team also includes Dr. Greg Charville, an assistant professor of pathology and Dr. Lipika Goyal, the new chief of GI oncology.
“I’ve met with [Goyal] a number of times about translational directions. She’s incredibly supportive of enhancing Stanford’s position as an international leader in both GI oncology trials as well as basic science efforts,” said Delitto.
Delitto is an assistant professor in the Division of General Surgery and was named a Warnock Faculty Scholar earlier this year.
Media Contact
Bio
About Stanford Surgery
The Stanford University Department of Surgery is dedicated to inventing the future of surgical care through:
• pioneering cutting-edge research,
• developing the next generation of leaders, and
• healing through incomparable surgical skills and compassion.
To learn more, please visit surgery.stanford.edu
The Latest
- – Surgery
INSIDE: PCSA2026
Two general surgery residents won awards at the Pacific Coast Surgical Association's 97th annual meeting this year in Oahu, Hawaii.
- – Surgery
INSIDE: ASC2026
Stanford Surgery trainees from across several disciplines presented at the 21st annual Academic Surgical Congress held in Orlando, Florida last week.
- – Surgery
Exploring the Intersection of Surgery and Cancer Research with Dr. Dan Delitto
Dr. Dan Delitto is an assistant professor of surgery at Stanford University specializes in surgical oncology and holds a PhD in immunology. On this episode, Dr. Delitto reflects on his decision to pursue an MD-PhD pathway during residency and discusses the recent advancements in single-cell RNA sequencing technology that his lab has acquired. He explains the complex role of fibroblasts in cancer development, particularly in pancreatic ductal carcinoma, highlighting how these cells can both promote and hinder tumor growth.
- – CAP Profiles
Dr. Clifford Sheckter Promoted to Associate Professor
Clifford Sheckter, MD, MS, FACS has been promoted to Associate Professor effective March 1, 2026. Dr. Sheckter works in the Division of Plastic and Reconstructive Surgery.
- – Abdominal Transplantation
INSIDE ASTS 2026: Stanford Abdominal Transplantation Surgery Recap
The American Society of Transplant Surgeons (ASTS) Winter Symposium was held January 22–25, 2026 at the Sheraton Grand at Wild Horse Pass in Phoenix, Arizona. The symposium brings together leading experts from across the field to share emerging research, discuss innovations in transplant care, and highlight key developments shaping the future of transplantation. There were several contributions from Stanford.